| 书目名称 | Prostate Cancer Prevention |
| 编辑 | Jack Cuzick,Mangesh A. Thorat |
| 视频video | http://file.papertrans.cn/762/761511/761511.mp4 |
| 概述 | Wide-ranging coverage of recent evidence on the prevention of prostate cancer, of interest for both clinicians and researchers.Detailed discussion of risk prediction biomarkers.Evaluation of the poten |
| 丛书名称 | Recent Results in Cancer Research |
| 图书封面 |  |
| 描述 | Prostate cancer is by far the most common cancer in men and the second leading cause of death due to cancer. It comprises a mixed group of tumours displaying varying clinical behaviour: while some have a very aggressive course, others are rather indolent. Prevention of prostate cancer and discrimination between aggressive and indolent forms are important clinical goals and the acquisition of significant new evidence on means of achieving these aims makes this book particularly timely. A wide range of topics are covered by leading authorities in the field. The biology and natural history of prostate cancer are reviewed and the role of lifestyle and dietary factors, assessed. Detailed attention is paid to risk prediction biomarkers and to the role of novel high-throughput nucleic acid-based technologies in improving risk prediction and thereby allowing tailored approaches to cancer prevention. Potential means of chemoprevention of prostate cancer are also reviewed in depth, covering the very positive new data on the impact of aspirin as well as evidence regarding 5α-reductase inhibitors, DFMO and lycopene. Guidance is provided on the differentiation of aggressive from indolent diseas |
| 出版日期 | Book 2014 |
| 关键词 | Biomarkers; Chemoprevention; Early Detection; Prostate Cancer; Risk-prevention |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-642-45195-9 |
| isbn_softcover | 978-3-662-52443-5 |
| isbn_ebook | 978-3-642-45195-9Series ISSN 0080-0015 Series E-ISSN 2197-6767 |
| issn_series | 0080-0015 |
| copyright | Springer-Verlag Berlin Heidelberg 2014 |
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-7-21 08:02
发表于 2025-3-21 19:11:06
